Catalio Capital Management, LP Sensei Biotherapeutics, Inc. Transaction History
Catalio Capital Management, LP
- $411 Billion
- Q1 2025
A detailed history of Catalio Capital Management, LP transactions in Sensei Biotherapeutics, Inc. stock. As of the latest transaction made, Catalio Capital Management, LP holds 294,374 shares of SNSE stock, worth $85,368. This represents 0.03% of its overall portfolio holdings.
Number of Shares
294,374
Previous 294,374
-0.0%
Holding current value
$85,368
Previous $144 Million
19.61%
% of portfolio
0.03%
Previous 0.03%
Shares
1 transactions
Others Institutions Holding SNSE
# of Institutions
23Shares Held
1.97MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA586KShares$169,8170.0% of portfolio
-
Ikarian Capital, LLC Dallas, TX450KShares$130,4890.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny177KShares$51,4170.0% of portfolio
-
Geode Capital Management, LLC Boston, MA151KShares$43,7050.0% of portfolio
-
Boothbay Fund Management, LLC New York, NY109KShares$31,5100.0% of portfolio
About Sensei Biotherapeutics, Inc.
- Ticker SNSE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 30,720,300
- Market Cap $8.91M
- Description
- Sensei Biotherapeutics, Inc., a biopharmaceutical company, engages in the discovery and development of immunotherapies with an initial focus on treatments for cancer. It develops proprietary ImmunoPhage platform, an immunotherapy approach that is designed to utilize bacteriophage to induce a focused and coordinated innate and adaptive immune res...